Copper Rock Capital Partners’s Pfizer PFE Stock Holding History

Copper Rock Capital Partners’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-130,549	Closed	-$4.17M	–	89
2017 Q2	$4.17M	Buy	130,549 +123,445	+1,738%	+$3.89M	0.27%	65
2017 Q1	$232K	Sell	7,104 -6,833	-49%	-$215K	0.01%	70
2016 Q4	$429K	Sell	13,937 -1,311	-9%	-$40K	0.03%	78
2016 Q3	$482K	Buy	15,248 +1,491	+11%	+$49.9K	0.03%	79
2016 Q2	$460K	Buy	+13,757	New	+$439K	0.03%	71
2014 Q3	–	Sell	-1,054	Closed	-$30K	–	114
2014 Q2	$30K	Hold	1,054	–	–	﹤0.01%	157
2014 Q1	$32K	Hold	1,054	–	–	﹤0.01%	221
2013 Q4	$31K	Hold	1,054	–	–	﹤0.01%	238
2013 Q3	$29K	Sell	1,054 -211	-17%	-$5.74K	﹤0.01%	243
2013 Q2	$34K	Buy	+1,265	New	+$35K	﹤0.01%	228

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Copper Rock Capital Partners's PFE Position: Q3 2017 in Review

Copper Rock Capital Partners sold out of Pfizer (PFE) in Q3 2017, closing a stake of 130,549 shares — an estimated $4.17M sold.

Copper Rock Capital Partners first reported a position in PFE in Q2 2013 and held it in 10 quarters. The position peaked at $4.17M in Q2 2017. 2,040 funds tracked by Wall St. Rank hold PFE as of Q3 2017.

Copper Rock Capital Partners reported no remaining Pfizer position as of Q3 2017 after selling out during the quarter.
Copper Rock Capital Partners sold 130,549 Pfizer shares in Q3 2017, an estimated $4.17M.
Copper Rock Capital Partners first reported a position in Pfizer in Q2 2013 and held it in 10 quarters.
Copper Rock Capital Partners's Pfizer position peaked at $4.17M in Q2 2017.
2,040 funds tracked by Wall St. Rank held Pfizer as of Q3 2017.

Based on Copper Rock Capital Partners's 13F filing for Q3 2017, filed 11 Oct 2017.